EIT Pharma is a biotechnology company based in Kirkland, Washington, focused on developing therapies for patients with serious viral diseases. In addition to lonafarnib for chronic hepatitis D, the company has obtained rights to lambda, which is being developed for severe acute viral respiratory tract infections. EIT Pharma was established by experienced clinical and biotechnology leaders to identify and advance overlooked or underdeveloped assets. At EIT Pharma, our focus is on advancing therapies where the unmet need is high, the science is rigorous, and the potential impact on patients is meaningful.

EIT Pharma, Inc.

Org chart

Teams

Offices

EIT Pharma, Inc.

Org chart

Teams

Offices

Related companies